For personal use only

Appendix 4D

Preliminary Final Report

________________________________________________________________________

Appendix 4D

Half Year Report to the Australian Stock

Exchange

Name of Entity

BTC health Limited

ABN

45 091 979 172

Half Year Ended

31 December 2021

Previous Corresponding

31 December 2020

Reporting Period

Results for Announcement to the Market

Percentage

31/12/2021

31/12/2020

increase /

(decrease)

$'000

$'000

over previous

corresponding

period

Revenue from ordinary activities

70

19

368.42%

Profit / (loss) from ordinary

(357)

(179)

199.44%

activities after tax attributable to

members

Net profit / (loss) for the period

(357)

(179)

199.44%

attributable to members

Dividends

Amount per security

Franked amount per

(distributions)

security

Dividend 31/12/21

Nil

Nil

Interim Dividend

Nil

Nil

Record date for determining entitlements

to the dividends (if any)

N/A

Brief explanation of any of the figures reported above necessary to enable the figures to be understood:

The company made a loss after tax during the half-year of $356,855 (Dec 2020: $178,942). Income increased $51,437 to $70,378 reflecting an increase in management fees received from the company's wholly owned investment, BTC Speciality Health Pty Ltd. Expenses of $427,233 increased $229,350 due to the cost of options issued $129,519, legal costs incurred associated with new investment opportunities $30,754,

________________________________________________________________________

For personal use only

Appendix 4D

Preliminary Final Report

________________________________________________________________________

non-recoverable GST $24,375, increase in insurance costs of $9,300 and an increase in listing fees of $8,936. The increase in other expenses comprises shareholder meetings and subscriptions. Cash balance at 31 December 2021 was $2,366,403 (June 2021: $2,368,975).

BTC held direct interests in two investment companies at 31 December 2021, BTC Speciality Health Pty Ltd and BioImpact Pty Ltd. The valuation of each investee company is recognised on the balance sheet. During the period BTC health has progressed the assessment of a number of potential additional investment opportunities, to further diversify investments in the healthcare sector.

BTC Speciality Health Pty Ltd

BTC health's wholly owned investee company BTC Speciality Health is an established distributor of medical devices and consumables in the Australian and New Zealand Public and Private Hospital market. Sales to Hospitals were $4.3m for the half-year ended December 2021 and grew 18.0%+ over prior year (Dec 20: $3.6m). Sales growth was driven by sales of respiratory products which were acquired from Pharmaxis on 1 July 2021. Sales of respiratory products were $0.7m, with sales of the infusion products being impacted by restrictions to elective surgery and limited hospital access. Despite global freight increases, the company maintained margin through product diversification and good stock control. Overheads were favourable 7.0%+ against plan, however increased 9.0%+, reflecting a greater cost of delivering ongoing education, training and conferences with clinicians, coupled with a reallocation of management costs. Hospital access and elective surgery rates are expected to improve in the short to medium term. The investment is valued at $6,000,000.

BioImpact Pty Ltd

BTC health wholly owns BioImpact, an investment company which licenses and holds intellectual property rights for healthcare products. The investment is valued at $2,000,100.

BTC health is a Pooled Development Fund, registered under the Pooled Development Funds Act 1992.

Dividends

Date the dividend is payable

N/A

Record date to determine

entitlement to the dividend

N/A

Amount per security

N/A

Total dividend

N/A

Amount per security of foreign

sourced dividend or distribution

N/A

Details of any dividend reinvestment

plans in operation

N/A

The last date for receipt of an

election notice for participation in

any dividend reinvestment plans

N/A

________________________________________________________________________

For personal use only

Appendix 4D

Preliminary Final Report

________________________________________________________________________

NTA Backing

Current Period

Previous

corresponding

period

Net tangible asset backing per

4.62 cents

4.49 cents

ordinary security

Control Gained Over Entities Having Material Effect

Name of entity (or group of entities)

None

Date control gained

N/A

Consolidated profit / (loss) from

N/A

ordinary activities since the date in the

current period on which control was

acquired

Profit / (loss) from ordinary activities of

N/A

the controlled entity (or group of

entities) for the whole of the previous

corresponding period

Loss of Control Gained Over Entities Having Material Effect

Name of entity (or group of entities)

None

Date control lost

N/A

Consolidated profit / (loss) from

N/A

ordinary activities for the current period

to the date of loss of control

Profit / (loss) from ordinary activities of

N/A

the controlled entity (or group of

entities) while controlled for the whole

of the previous corresponding period

Details of Associates and Joint Venture Entities

Name of Entity

Percentage Held

Share of Net Profit

Current

Previous

Current

Previous

Period

Period

Period

Period

None

N/A

N/A

N/A

N/A

Aggregate Share of Net

N/A

N/A

N/A

N/A

Profits

Foreign Entities Accounting Framework

For foreign entities provide details of which accounting standards have been adopted (e.g. International Accounting Standards)

N/A

________________________________________________________________________

For personal use only

Appendix 4D

Preliminary Final Report

________________________________________________________________________

Audit/Review Status

This report is based on accounts to which one of the following applies: (Tick one)

The accounts have been audited

The accounts have been subject

✓

to review

If the accounts are subject to audit dispute or qualification, a description of the dispute or qualification:

N/A

Attachments Forming Part of Appendix 4D

Attachment #

Details

1

Interim Financial Report

Signed by Company Secretary

Print Name

Sharon Papworth

Date

15 February 2022

________________________________________________________________________

For personal use only

BTC HEALTH LIMITED

ABN 45 091 979 172

HALF-YEAR FINANCIAL REPORT

FOR THE HALF-YEAR ENDED

31 DECEMBER 2021

1

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

BTC Health Limited published this content on 15 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 February 2022 07:06:06 UTC.